Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Dianthus Therapeutics has the lowest figure of the 43 pharmaceuticals ranked by operating margin, at -8739%, followed by Roivant Sciences (-6236%) and Cytokinetics (-695%). Figures as of 18 Nov 2026, 12:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- Lowest
- Dianthus Therapeutics-8739%
- Median
- 12.5%
- Combined market value
- PLN 20.75T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Dianthus TherapeuticsDNTH · Health Care | -8739% | PLN 19.7B | PLN 349.83 | 2.87% down | 113% up | ||
| 2 | Roivant SciencesROIV · Health Care | -6236% | PLN 112.8B | PLN 155.69 | 0.26% up | 90% up | ||
| 3 | CytokineticsCYTK · Health Care | -695% | PLN 28.9B | PLN 207.73 | 2.86% down | 20% down | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | -344% | PLN 32.7B | PLN 501.42 | 0.13% down | 46% up | ||
| 5 | InsmedINSM · Health Care | -206% | PLN 107.5B | PLN 490.11 | 0.83% down | 40% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -104% | PLN 60.2B | PLN 308.89 | 0.72% down | 17% up | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | PLN 32.5B | PLN 469.00 | 8.49% up | 13% up | ||
| 8 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | PLN 18.1B | PLN 108.43 | 3.75% down | 64% down | ||
| 9 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | PLN 39.4B | PLN 1,697.22 | 0.46% down | 24% down | ||
| 10 | Axsome TherapeuticsAXSM · Health Care | -26.1% | PLN 28.8B | PLN 546.78 | 0.77% down | 7% down | ||
| 11 | Ascendis PharmaASND · Health Care | -18.9% | PLN 71.5B | PLN 1,090.71 | 0.20% down | 28% up | ||
| 12 | ViatrisVTRS · Health Care | -18.6% | PLN 94.3B | PLN 82.25 | 1.40% down | 96% up | ||
| 13 | Legend BiotechLEGN · Health Care | -13.3% | PLN 12.6B | PLN 64.79 | 0.75% up | 42% down | ||
| 14 | Travere TherapeuticsTVTX · Health Care | -12.8% | PLN 19.7B | PLN 205.52 | 2.82% up | 44% up | ||
| 15 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | PLN 62.1B | PLN 968.12 | 0.39% up | 37% up | ||
| 16 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | PLN 24.1B | PLN 369.82 | 0.40% up | 31% up | ||
| 17 | Takeda PharmaceuticalTAK · Health Care | 0.14% | PLN 278.1B | PLN 87.03 | 0.23% up | 54% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | 5.88% | PLN 30.8B | PLN 281.82 | 1.23% up | 8% down | ||
| 19 | BeOne MedicinesONC · Health Care | 8.37% | PLN 189.9B | PLN 1,662.11 | 0.48% up | 17% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | PLN 30.1B | PLN 382.53 | 0.93% up | 126% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | PLN 24.4B | PLN 172.90 | 2.76% down | 10% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | PLN 200B | PLN 171.42 | 0.12% up | 74% up | ||
| 23 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | PLN 45.6B | PLN 235.32 | 0.90% up | 11% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | PLN 29.6B | PLN 84.94 | 0.52% down | 83% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | PLN 84.3B | PLN 629.44 | 2.02% down | 66% down | ||
| 26 | SanofiSNY · Health Care | 14.5% | PLN 459B | PLN 191.16 | 1.78% down | 4% down | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | PLN 49.6B | PLN 59.48 | 0.61% up | 5% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | PLN 23.6B | PLN 1,181.69 | 2.62% down | 43% up | ||
| 29 | GrifolsGRFS · Health Care | 16.5% | PLN 23.6B | PLN 34.71 | 1.15% down | 1% up | ||
| 30 | AlkermesALKS · Health Care | 17.2% | PLN 30.7B | PLN 182.80 | 2.32% down | 58% up | ||
| 31 | Abbott LaboratoriesABT · Health Care | 18.2% | PLN 729.4B | PLN 421.14 | 2.55% down | 17% down | ||
| 32 | TG TherapeuticsTGTX · Health Care | 20.0% | PLN 38.1B | PLN 252.22 | 0.08% down | 107% up | ||
| 33 | AstraZenecaAZN · Health Care | 23.4% | PLN 1.14T | PLN 733.08 | 0.95% down | 2% up | ||
| 34 | GSKGSK · Health Care | 24.3% | PLN 397B | PLN 198.04 | 2.32% down | 6% up | ||
| 35 | AbbVieABBV · Health Care | 24.6% | PLN 2.08T | PLN 1,177.71 | 0.59% down | 26% up | ||
| 36 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | PLN 398.5B | PLN 3,852.06 | 0.56% up | 36% up | ||
| 37 | GenmabGMAB · Health Care | 28.6% | PLN 128.9B | PLN 208.98 | 0.76% up | 70% up | ||
| 38 | NovartisNVS · Health Care | 32.4% | PLN 1.21T | PLN 640.01 | 0.67% down | 25% up | ||
| 39 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | PLN 544.7B | PLN 2,148.53 | 0.67% down | 27% up | ||
| 40 | Novo NordiskNVO · Health Care | 41.3% | PLN 721.5B | PLN 163.69 | 2.16% down | 17% down | ||
| 41 | United TherapeuticsUTHR · Health Care | 46.9% | PLN 100.1B | PLN 2,349.22 | 0.64% down | 23% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | 50.1% | PLN 20.3B | PLN 242.76 | 1.00% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | 65.6% | PLN 158.8B | PLN 276.23 | 0.23% up | 78% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0220 PLN). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest operating margin?
Dianthus Therapeutics (-8739%), Roivant Sciences (-6236%) and Cytokinetics (-695%) have the lowest operating margin of the 43 pharmaceuticals ranked here as of 18 Nov 2026, 12:59 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of PLN 20.75T as of 18 Nov 2026, 12:59 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.